AI hunts for liver cancer before it strikes
NCT ID NCT07160946
Summary
This study aims to use artificial intelligence (AI) to analyze health data and better predict which people with hepatitis B and liver cirrhosis are at highest risk of developing liver cancer. It will enroll 6,000 high-risk participants to create a more precise follow-up and monitoring system. The main goal is to catch liver cancer earlier, when it is more treatable, by improving risk assessment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HBV-RELATED LIVER CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Third Affiliated Hospital of Sun Yat-sen University
RECRUITINGGuangzhou, Guangdong, 510630, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.